CAS: 8069-64-5; Meralluride

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-10925977-B2
      优先权日:2006-10-05
      标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
      发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
      权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
      摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

      专利号:US-2008287407-A1
      优先权日:2003-12-10
      标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
      发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
      权利人:NITROMED INC
      摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

      专利号:AU-2007308022-A2
      优先权日:2006-10-05
      标题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

      专利号:AU-2007308022-A1
      优先权日:2006-10-05
      标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

      专利号:US-2008107598-A1
      优先权日:2006-10-05
      标 题:Efficient Synthesis of Chelators for Nuclear Imaging and Radiotherapy: Compositions and Applications

      专利号:AU-2007308022-B2
      优先权日:2006-10-05
      标题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Siegel W, Gifford RW Jr. Efficacy of ethacrynic acid in patients with refractory congestive heart failure resistant to meralluride. Am J Cardiol. 1968 Aug;22(2):260-5. doi: 10.1016/0002-9149(68)90232-4. 8(2):195-201. doi: 10.1016/0021-9681(58)90191-7. 37(3):707-14. 20(2):352-61. doi: 10.1111/j.1476-5381.1963.tb01474.x.
      5: KESSLER RH, LOZANO R, PITTS RF. A comparison of the pharmacological behavior of chlormerodrin, meralluride, mersalyl and mercuric chloride in the dog. J Pharmacol Exp Ther. 1957 Dec;121(4):432-42. 65(5):511-9. doi: 10.1111/j.1749-6632.1956.tb36656.x. 16(11):2163-9. doi: 10.1016/0006-2952(67)90015-9.
      141:326-32. 247(16):593-6. doi: 10.1056/NEJM195210162471602. 5(5):493-7. doi: 10.1161/01.res.5.5.493. 123(4):311-5. 51(11):1410-2. 105(6):321-34. doi: 10.1159/000202062. 50(2):157-9. French. 48(5):780-4. doi: 10.1016/0002-8703(54)90069-1. 21(12):711-8. doi: 10.1016/0020-708x(70)90080-3. 49(10):904-6.

      合成参考文献


      摘要:Journal of Pharmacology and Experimental Therapeutics., 105(336), 1952 []
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知